CNS activity of trastuzumab deruxtecan in HER2-expressing non-small-cell lung cancer

Anna-Maria Lazaratos(McGill University), Matthew Dankner(McGill University), Kevin Petrecca(McGill University Health Centre), Katarzyna J. Jerzak(Sunnybrook Health Science Centre), Marie‐Christine Guiot(McGill University)
The Lancet Oncology
June 24, 2024
Cited by 3


Related Papers